Monoclonal Mouse anti‑All species Dityrosine Antibody (clone 7D4, Atto 390, IF, WB) LS‑C821084
Monoclonal Mouse anti‑All species Dityrosine Antibody (clone 7D4, Atto 390, IF, WB) LS‑C821084
Antibody:
Dityrosine Mouse Monoclonal (Atto 390) (7D4) Antibody
Application:
IF, WB, ELISA
Format:
Atto 390, Unmodified
Overview
Antibody:
Dityrosine Mouse Monoclonal (Atto 390) (7D4) Antibody
Application:
IF, WB, ELISA
Format:
Atto 390, Unmodified
Specifications
Description
Dityrosine antibody LS-C821084 is an Atto 390-conjugated mouse monoclonal antibody to all species Dityrosine. Validated for ELISA, IF and WB.
Target
All species Dityrosine
Clonality
IgG1
Monoclonal
Conjugations
Atto 390.
Also available conjugated with
Atto 488,
Atto 594,
APC,
Biotin,
FITC,
PerCP,
RPE.
Purification
Protein G purified
Immunogen
Synthetic Dityrosine conjugated to Keyhole Limpet Hemocyanin (KLH).
Specificity
Specific for dityrosine modified proteins. Does not cross-react with 3,5-dibromotyrosine or bromotyrosine modified proteins.
Applications
- Immunofluorescence (1:50)
- Western blot (1:1000)
- ELISA (1:1000)
- Applications tested for the base form of this product only
Usage
A 1:1000 dilution of the antibody was sufficient for detection of dityrosine in 1 µg of Dityrosine conjugated to BSA by ECL immunoblot analysis using Goat Anti-Mouse IgG:HRP as the secondary Antibody. Applications should be user optimized.
Presentation
PBS, pH 7.4, 0.09% Sodium Azide, 50% Glycerol
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Reactivity:
Human
Range:
0.16-10 ng/ml
Reactivity:
Human
Range:
3.12-200 ng/ml
Reactivity:
Human
Range:
1.56-100 ng/ml
Reactivity:
Human
Range:
1.56-100 ng/ml
Reactivity:
Human
Range:
0.312-20 ng/ml
Reactivity:
Human
Range:
0.156-10 ng/ml
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 6/29/2024